Heron Therapeutics (NASDAQ:HRTX) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Heron Therapeutics (NASDAQ:HRTX – Free Report) from a hold rating to a buy rating in a research report report published on Friday morning. Separately, Needham & Company LLC reissued a “buy” rating and set a $4.00 price target on shares of Heron Therapeutics in a research report on Friday, […]
Wall Street Zen upgraded shares of Heron Therapeutics (NASDAQ:HRTX – Free Report) from a hold rating to a buy rating in a research report report published on Friday morning. Separately, Needham & Company LLC reissued a “buy” rating and set a $4.00 price target on shares of Heron Therapeutics in a research report on Friday, […]
